Northern Trust Corp Stoke Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 339,153 shares of STOK stock, worth $4.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

339,153

Previous 282,615 20.01%

Holding current value

$4.08 Million

Previous $3.82 Million 9.17%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$12.24 - $15.92 $692,025 - $900,084	56,538 Added 20.01%	339,153 $4.17 Million
Q2 2024 Aug 14, 2024	BUY	$11.03 - $17.52 $239,615 - $380,604	21,724 Added 8.33%	282,615 $3.82 Million
Q1 2024 May 14, 2024	BUY	$4.12 - $14.17 $13,591 - $46,746	3,299 Added 1.28%	260,891 $3.52 Million
Q4 2023 Feb 13, 2024	SELL	$3.37 - $5.4 $26,221 - $42,017	-7,781 Reduced 2.93%	257,592 $1.35 Million
Q3 2023 Nov 13, 2023	SELL	$3.78 - $11.99 $10,440 - $33,116	-2,762 Reduced 1.03%	265,373 $1.05 Million
Q2 2023 Aug 11, 2023	BUY	$7.93 - $13.82 $565,837 - $986,112	71,354 Added 36.26%	268,135 $2.85 Million
Q1 2023 May 15, 2023	SELL	$7.65 - $10.38 $13,272 - $18,009	-1,735 Reduced 0.87%	196,781 $1.64 Million
Q4 2022 Feb 13, 2023	SELL	$7.07 - $15.69 $36,756 - $81,572	-5,199 Reduced 2.55%	198,516 $1.83 Million
Q3 2022 Nov 14, 2022	SELL	$12.56 - $22.53 $26,200 - $46,997	-2,086 Reduced 1.01%	203,715 $2.62 Million
Q2 2022 Aug 12, 2022	BUY	$10.36 - $23.93 $198,559 - $458,642	19,166 Added 10.27%	205,801 $2.72 Million
Q1 2022 May 13, 2022	BUY	$17.19 - $26.1 $4,314 - $6,551	251 Added 0.13%	186,635 $3.93 Million
Q4 2021 Feb 08, 2022	SELL	$18.11 - $30.72 $10,105 - $17,141	-558 Reduced 0.3%	186,384 $4.47 Million
Q3 2021 Nov 15, 2021	SELL	$23.65 - $34.44 $243,831 - $355,076	-10,310 Reduced 5.23%	186,942 $4.76 Million
Q2 2021 Aug 13, 2021	BUY	$30.53 - $41.09 $323,373 - $435,225	10,592 Added 5.67%	197,252 $6.64 Million
Q1 2021 May 12, 2021	SELL	$36.08 - $69.81 $480,224 - $929,171	-13,310 Reduced 6.66%	186,660 $7.25 Million
Q4 2020 Feb 11, 2021	BUY	$33.62 - $61.93 $181,985 - $335,227	5,413 Added 2.78%	199,970 $12.4 Million
Q3 2020 Nov 16, 2020	BUY	$22.23 - $37.48 $102,191 - $172,295	4,597 Added 2.42%	194,557 $6.52 Million
Q2 2020 Aug 14, 2020	SELL	$20.26 - $29.73 $226,446 - $332,292	-11,177 Reduced 5.56%	189,960 $4.53 Million
Q1 2020 May 14, 2020	BUY	$16.8 - $34.15 $1.41 Million - $2.86 Million	83,733 Added 71.32%	201,137 $4.61 Million
Q4 2019 Feb 14, 2020	BUY	$20.01 - $30.79 $190,255 - $292,751	9,508 Added 8.81%	117,404 $3.33 Million
Q3 2019 Nov 13, 2019	BUY	$20.53 - $37.72 $2.22 Million - $4.07 Million	107,896 New	107,896 $2.32 Million

Others Institutions Holding STOK

# of Institutions

123

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $474M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Stoke Therapeutics, Inc. Transaction History